Dose-dependent restoration of dystrophin expression in cardiac muscle of dystrophic mice by systemically delivered morpholino (Q43275640)

18 November 2017

Dose-dependent restoration of dystrophin expression in cardiac muscle of dystrophic mice by systemically delivered morpholino (English)

1 reference

18 November 2017

E Benrashid

3

0 references

author name string

B Wu

1

1 reference

18 November 2017

P Lu

2

1 reference

18 November 2017

S Malik

4

1 reference

18 November 2017

J Ashar

5

1 reference

18 November 2017

T J Doran

6

1 reference

18 November 2017

Q L Lu

7

1 reference

18 November 2017

17 September 2009

1 reference

18 November 2017

1 reference

18 November 2017

17

1 reference

18 November 2017

1

1 reference

18 November 2017

132-140

1 reference

https://scigraph.springernature.com/pub.10.1038/gt.2009.120

18 November 2017

0 references

cites work

Complete cloning of the duchenne muscular dystrophy (DMD) cDNA and preliminary genomic organization of the DMD gene in normal and affected individuals

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.120

Preservation of the C-terminus of dystrophin molecule in the skeletal muscle from Becker muscular dystrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.120

LGMD2I presenting with a characteristic Duchenne or Becker muscular dystrophy phenotype.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.120

Very mild muscular dystrophy associated with the deletion of 46% of dystrophin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.120

Adeno-associated virus vector carrying human minidystrophin genes effectively ameliorates muscular dystrophy in mdx mouse model

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.120

Functional amounts of dystrophin produced by skipping the mutated exon in the mdx dystrophic mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.120

Systemic delivery of antisense oligoribonucleotide restores dystrophin expression in body-wide skeletal muscles

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.120

Systemic delivery of morpholino oligonucleotide restores dystrophin expression bodywide and improves dystrophic pathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.120

Efficacy of systemic morpholino exon-skipping in Duchenne dystrophy dogs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.120

Comparative analysis of antisense oligonucleotide sequences for targeted skipping of exon 51 during dystrophin pre-mRNA splicing in human muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.120

Gene therapy progress and prospects: Duchenne muscular dystrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.120

Current treatment of adult Duchenne muscular dystrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.120

Emergent dilated cardiomyopathy caused by targeted repair of dystrophic skeletal muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.120

Visualization of dystrophic muscle fibers in mdx mouse by vital staining with Evans blue: evidence of apoptosis in dystrophin-deficient muscle.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.120

Prevention of dystrophin-deficient cardiomyopathy in twenty-one-month-old carrier mice by mosaic dystrophin expression or complementary dystrophin/utrophin expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.120

Effective rescue of dystrophin improves cardiac function in dystrophin-deficient mice by a modified morpholino oligomer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.120

Octa-guanidine morpholino restores dystrophin expression in cardiac and skeletal muscles and ameliorates pathology in dystrophic mdx mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.120

Antisense technologies. Improvement through novel chemical modifications

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.120

Morpholino antisense oligomers: design, preparation, and properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.120

Adult cardiac stem cells are multipotent and support myocardial regeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.120

Cardiac progenitor cells from adult myocardium: Homing, differentiation, and fusion after infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.120

Clinical-molecular correlation in 104 mild X-linked muscular dystrophy patients: characterization of sub-clinical phenotypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.120

7 January 2021

Local dystrophin restoration with antisense oligonucleotide PRO051

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.120

7 January 2021

Evolution of the mdx mouse cardiomyopathy: physiological and morphological findings

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.120

7 January 2021

Culture and adenoviral infection of adult mouse cardiac myocytes: methods for cellular genetic physiology

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.120

7 January 2021

The cellular basis of pacing-induced dilated cardiomyopathy. Myocyte cell loss and myocyte cellular reactive hypertrophy

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.120

7 January 2021

Identifiers

DOI

10.1038/GT.2009.120

1 reference

Dimensions Publication ID

18 November 2017

0 references

1 reference